Hsu‐Shan Huang

Also affiliated with National Defense Medical Center

Pharmacology, Toxicology and PharmaceuticsBiochemistry, Genetics and Molecular BiologyChemistry

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: “LCC-09, a Novel Salicylanilide Derivative, Exerts Anti-Inflammatory Effect in Vascular Endothelial Cells”.

LCC-09, a Novel Salicylanilide Derivative, Exerts Anti-Inflammatory Effect in Vascular Endothelial Cells

Journal of Inflammation Research(2021)10.2147/jir.s305168

N/A

0.292DataRank · unranked

6 citations

Jian Zhu, Alexander T.H. Wu, Maryam Rachmawati Sumitra, Victoria C. Pham, Shamit K. Dutta +7 more

mTOR/EGFR/iNOS/MAP2K1/FGFR/TGFB1 Are Druggable Candidates for N-(2,4-Difluorophenyl)-2′,4′-Difluoro-4-Hydroxybiphenyl-3-Carboxamide (NSC765598), With Consequent Anticancer Implications

Frontiers in Oncology(2021)10.3389/fonc.2021.656738

N/A

0DataRank · unranked

51 citations

Ching‐Yu Lee, Ntlotlang Mokgautsi, Maryam Rachmawati Sumitra, Harshita Khedkar, Alexander T.H. Wu +2 more

Pro-Oncogenic c-Met/EGFR, Biomarker Signatures of the Tumor Microenvironment are Clinical and Therapy Response Prognosticators in Colorectal Cancer, and Therapeutic Targets of 3-Phenyl-2H-benzo[e][1,3]-Oxazine-2,4(3H)-Dione Derivatives

Frontiers in Pharmacology(2021)10.3389/fphar.2021.691234

N/A

0DataRank · unranked

32 citations

Yu‐Chi Wang, Alexander T.H. Wu, Hsu‐Shan Huang, Bashir Lawal

In vivo Pharmacokinetic and Anticancer Studies of HH-N25, a Selective Inhibitor of Topoisomerase I, and Hormonal Signaling for Treating Breast Cancer

Journal of Inflammation Research(2021)10.2147/jir.s329401

N/A

0DataRank · unranked

28 citations

Yu-Cheng Kuo, Maryam Rachmawati Sumitra, Alexander T.H. Wu, Hsu‐Shan Huang, Bashir Lawal

BC-N102 suppress breast cancer tumorigenesis by interfering with cell cycle regulatory proteins and hormonal signaling, and induction of time-course arrest of cell cycle at G1/G0 phase

International Journal of Biological Sciences(2021)10.7150/ijbs.62808

N/A

0DataRank · unranked

13 citations

Yu-Cheng Kuo, Alexander T.H. Wu, Hsu‐Shan Huang, Bashir Lawal

Structure-based design, synthesis and biological evaluation of N-substituted 6H-thiochromeno[2,3–c]quinolin-12(12H)-one as potential breast cancer drugs

Arabian Journal of Chemistry(2023)10.1016/j.arabjc.2023.105423

N/A

0DataRank · unranked

4 citations

Lung-Ching Chen, W.-C. Tsai, Muhamad Ansar, Bashir Lawal, Ntlotlang Mokgautsi +4 more